Cargando…
Common deficiencies found in generic Finished Pharmaceutical Product (FPP) applications submitted for registration to the South African Health Products Regulatory Authority (SAHPRA)
BACKGROUND: The aim of the study was to investigate the common deficiencies observed in the Finished Pharmaceutical Product (FPP) section of generic product applications submitted to SAHPRA. The study was conducted retrospectively over a 7-year period (2011–2017) for products that were finalised by...
Autores principales: | Moeti, Lerato, Litedu, Madira, Joubert, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753817/ https://www.ncbi.nlm.nih.gov/pubmed/35022074 http://dx.doi.org/10.1186/s40545-021-00398-5 |
Ejemplares similares
-
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022
por: Moeti, Lerato, et al.
Publicado: (2023) -
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA)
por: Moeti, Lerato, et al.
Publicado: (2023) -
Protection of data submitted for the registration of pharmaceuticals : implementing the standards of the trips agreement /
por: Correa, Carlos María
Publicado: (2002) -
Status of FPP Project D-082
por: Allardyce, B W
Publicado: (1994) -
Combinatorial Metabolic Engineering in Saccharomyces cerevisiae for the Enhanced Production of the FPP-Derived Sesquiterpene Germacrene
por: Bröker, Jan Niklas, et al.
Publicado: (2020)